K972094

Substantially Equivalent

TARGET CARDIAC TROPONIN I TEST

Applicant: Texas Immunology, Inc.
Product code: MMI
Advisory panel: Clinical Chemistry
Date received: 1997-06-04
Decision date: 1997-07-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tyler, TX, US

Adverse events under product code MMI

product code MMI

Injury: 172
Malfunction: 3,762
Total: 3,934

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.